Literature DB >> 1453527

Academic-industry relationships in the life sciences. Extent, consequences, and management.

D Blumenthal1.   

Abstract

Academic-industry relationships in the life sciences remain controversial. The available evidence suggests that such relationships have both benefits and risks for involved parties. Benefits include additional support of academic research, income for academic health centers, the potential for increased scientific and commercial productivity in both industries and universities, and enhancement of the educational experiences of students and fellows. Risks include an increase in secrecy in academic environments and damage to public support for the life science enterprise. The balance of known benefits and risks suggests that academic-industry relationships should be permitted and even selectively promoted. However, there is also a need for enhanced vigilance on the part of academic institutions and government to reduce risks posed by certain types of arrangements, especially those involving human subjects. Enhanced vigilance should include disclosure of all academic-industry relationships by life science faculty.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1992        PMID: 1453527

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

Review 1.  Patenting human genetic material: refocusing the debate.

Authors:  T Caulfield; E R Gold; M K Cho
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

2.  The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.

Authors:  Marvin R Natowicz; Catherine Ard
Journal:  J Genet Couns       Date:  1997-09       Impact factor: 2.537

Review 3.  Evidence-based ethics for neurology and psychiatry research.

Authors:  Scott Y H Kim
Journal:  NeuroRx       Date:  2004-07

4.  The value of commercial funding in health services research: the case of the APACHE III methodology.

Authors:  W A Knaus; J C LaRosa; R D Marks; G E Bisbee
Journal:  Health Serv Res       Date:  1994-02       Impact factor: 3.402

5.  Commercialisation of genetic diagnostic services.

Authors:  R Hoedemaekers; H ten Have
Journal:  Med Health Care Philos       Date:  1998

6.  Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest.

Authors:  Eric M Meslin; Joshua B Rager; Peter H Schwartz; Kimberly A Quaid; Margaret M Gaffney; Jon Duke; William H Tierney
Journal:  Clin Transl Med       Date:  2015-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.